Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/19652060

J. Clin. Oncol. 2009 Sep 20 27 27 4462-8

Download in:

View as

Triples

General Info

PMID
19652060